BioSpace News Archive

Prefilled formalin vials are clarified containers that allow easy visualization of samples in the healthcare industries.

Oncopeptides AB, a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has published the report for the third quarter 2021.

Selvita – one of the largest preclinical contract research organizations in Europe continues its dynamic development. Following the acquisition of Fidelta, Selvita Group achieved in the three quarters of 2021 over a two-fold increase in sales revenue comparing to the corresponding period of the previous year.

Ionis Pharmaceuticals, Inc. today announced that Pfizer has provided an update on the Phase 2b study of vupanorsen, formerly IONIS-ANGPTL3-L.

InDex Pharmaceuticals Holding AB (publ) today announced that the first patient has been enrolled in the pivotal phase III study CONCLUDE.

Avisa Diagnostics Inc. reports that, due to current liquidity limitations, the Company does not anticipate that it will be able to file its unaudited financial statements for the period ended September 30, 2021, related management discussion and analysis and applicable CEO and CFO certifications by the filing deadline of November 29, 2021.

Algernon Pharmaceuticals Inc. is pleased to announce that it has received positive feedback from the U.S. Food and Drug Administration (U.S. FDA) at its pre-IND (Investigational New Drug) meeting for its investigation of NP-120 (Ifenprodil) for the treatment of small cell lung cancer (SCLC).

GreenLight Biosciences and Samsung Biologics announced a partnership agreement in which Samsung Biologics will manufacture GreenLight’s messenger RNA COVID-19 vaccine candidate at commercial scale.

Seres Therapeutics to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference.

Castle Biosciences, Inc. today announced oral presentations on its DecisionDx® gene expression profile (GEP) tests for skin cancer at the American Society for Dermatologic Surgery (ASDS) 2021 Annual Meeting, held Nov. 19-21, 2021.